Loading page content…
Loading page content…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | The Royal Marsden NHS Foundation Trust |
| Main Category: | Goods |
| Procurement Method: | Award procedure without prior publication of a call for competition |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 16 May 2022 |
| Application Deadline: | — |
| Procurement ID (OCID): | ocds-h6vhtk-0337ca |
| Notice Reference: | 012588-2022 |
.The Royal Marsden Hospital requires purchase of ANMI PSMA Setrile 360 VIALS and ANMI Elution Tools Gen A to treat prostate cancer. ANMI PSMA Setrile 360 Vials and ANMI Elution Tools Gen A is the only viable kit for imaging of prostate cancer, disease progression or staging of cancer in UK. There is no licensed product in the UK at the moment, XIEL is the only official UK Distributor of the ANMI HBEDCC-11 PSMA Kit and follows the Regulated Import Pathway approved by the MHRA for this product.
Published contracts in the last 12 months
34
total contracts
£7.9m
total value
£1,126,000
average contract size
Typical categories
Prior Information Notice (PIN) for an innovation partnership to develop Artificial Intelligence (AI) in mammography
The Royal Marsden NHS Foundation Trust · WAC-148670
The Royal Marsden NHS Foundation Trust Magazine Design and Print
The Royal Marsden NHS Foundation Trust · WAC-148847
Pipeline status
Not addedContract imported automatically · AI writes the response
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →